Fertility News and Research RSS Feed - Fertility News and Research

Promising molecular diagnostic approach to endometriosis

Promising molecular diagnostic approach to endometriosis

Researchers at UC San Francisco have identified patterns of genetic activity that can be used to diagnose endometriosis and its severity, a finding that may offer millions of women an alternative to surgery through a simple noninvasive procedure. [More]
Snus consumption in Norway is highest among young people

Snus consumption in Norway is highest among young people

The increase in Scandinavian snus consumption in Norway is highest among young people, according to a new report from the Norwegian Institute of Public Health. [More]
Research reveals critical role natural antioxidant selenium plays in woman's fertility

Research reveals critical role natural antioxidant selenium plays in woman's fertility

University of Adelaide research has for the first time shown how much of a critical role the natural antioxidant selenium plays at the earliest stages of a woman's fertility. [More]
Preterm birth becomes world's number one killer of young children

Preterm birth becomes world's number one killer of young children

For the first time in history, the complications of preterm birth outrank all other causes as the world's number one killer of young children. [More]
FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. [More]
LSU Health New Orleans receives grant to support young breast cancer survivors in the Gulf South

LSU Health New Orleans receives grant to support young breast cancer survivors in the Gulf South

The LSU Health New Orleans School of Public Health has been awarded a $2.2 million grant to increase the availability of health information and support services for young breast cancer survivors in the Gulf South. [More]
March of Dimes calls for nationwide effort to reduce U.S. preterm births to 5.5% by 2030

March of Dimes calls for nationwide effort to reduce U.S. preterm births to 5.5% by 2030

The March of Dimes is calling for a nationwide effort to reduce U.S. preterm births to 5.5 percent of all live births by 2030. Seven other developed countries already have preterm birth rates below 6 percent, and 15 have rates below 7 percent. [More]
Prenatal exposure to phthalate DiNP associated with shorter AGD in Swedish boys: Study

Prenatal exposure to phthalate DiNP associated with shorter AGD in Swedish boys: Study

The first study to examine prenatal exposure to the phthalate DiNP finds it is associated with a shorter anogenital distance (AGD) in Swedish boys at the age of 21 months. These findings raise concern since animal research has linked DiNP exposure to a shorter AGD, and studies on humans have related shorter AGD to male genital birth defects as well as impaired reproductive function in adult males, and the levels of DiNP metabolites in humans are increasing globally. [More]
Study sheds light on the mystery of biological clock that controls fertility in women

Study sheds light on the mystery of biological clock that controls fertility in women

Researchers at the University of Gothenburg have identified the biological clock that governs female fertility. The discovery represents a major contribution to research aimed at finding medical approaches to treating infertility in women. [More]
UMass Amherst epidemiologist investigates risk of early menopause

UMass Amherst epidemiologist investigates risk of early menopause

The estimated 10 percent of women in Western nations who enter menopause before age 45 have an elevated risk of cardiovascular disease, as well as lower fertility. Now epidemiologist Elizabeth Bertone-Johnson at the University of Massachusetts Amherst is conducting the first large study to investigate whether vitamin D deficiency, inflammatory factors, hormones and other factors are associated with risk of early menopause, funded by NIH. [More]
New research suggests that exposure to aluminium may reduce male fertility

New research suggests that exposure to aluminium may reduce male fertility

And the team of scientists, at the universities of Lyon and Saint-Etienne in France and Keele in the UK, found that the higher the aluminium, the lower sperm count. [More]
Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company, has announced the launch of its lead product Rasuvo (methotrexate) injection for patients with rheumatoid arthritis (RA), poly-articular-course juvenile idiopathic arthritis (pJIA) and psoriasis in the U.S. [More]
Silicon Valley using health care perks to lure talent

Silicon Valley using health care perks to lure talent

High salaries and free food aren't enough any more in Silicon Valley, where maturing companies are competing for talent with creative health care and "wellness" programs that use gadgets to promote good behavior. Standard benefits at the largest technology companies, including Google Inc and Apple Inc, range from fertility treatments to deluxe on-site medical clinics, to new technology treats like health-tracking bracelets. The health largesse separates Silicon Valley's raging economy from many other sectors in the United States, but tech companies' experiments with perks show signs of spreading, benefits managers say. [More]
Chemotherapy, radiotherapy have no negative effect on unborn babies

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown. [More]
EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million. [More]
New NIH program awards $2.5 million to spur innovation in mobile health

New NIH program awards $2.5 million to spur innovation in mobile health

A new NIH program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs). [More]
Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare & Select" feature in the EmbryoViewer software - an accessory to the EmbryoScope time-lapse incubator - which assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals wishing to become a parent. [More]
Study addresses challenge of developing effective strategies to prevent gender-based violence

Study addresses challenge of developing effective strategies to prevent gender-based violence

Gender-based violence affects the physical and mental health of girls and boys, men and women worldwide. A recent study by researchers from the Institute for Reproductive Health at Georgetown University addresses the challenge of developing effective strategies to change inequitable and harmful social norms that result in gender-based violence. [More]
High impact health interventions reduce maternal and child mortality in poor countries

High impact health interventions reduce maternal and child mortality in poor countries

New studies have uncovered the specific interventions and advances that have led to the success with these at-risk populations in the poorest countries. [More]
Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. [More]